MLchartDataset catalogue

CRA-024781

Term · Oncology and biomedicine · MLC-T-ONC-002123

A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-002123
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-002123",
  "term": "CRA-024781",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/cra-024781/"
}

Record 5,408 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.